Nombre del producto:Methyl 3-Amino-2-Chloro-6-Fluorobenzoate

IUPAC Name:methyl 3-amino-2-chloro-6-fluorobenzoate

CAS:1268830-74-5
Fórmula molecular:C8H7ClFNO2
Pureza:95%+
Número de catálogo:CM448010
Peso molecular:203.6

Unidad de embalaje Stock disponible Precio($) Cantidad
CM448010-100mg 3-4 Weeks ǕȌDz
CM448010-250mg 3-4 Weeks ȦDzƤ
CM448010-1g 4-5 Weeks ȌɐȦ
CM448010-5g 5-6 Weeks ǕɐƱȷ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1268830-74-5
Fórmula molecular:C8H7ClFNO2
Punto de fusión:-
Código de sonrisas:COC(=O)C1=C(Cl)C(N)=CC=C1F
Densidad:
Número de catálogo:CM448010
Peso molecular:203.6
Punto de ebullición:
Nº Mdl:MFCD24646162
Almacenamiento:

Column Infos

Tinlorafenib
The Journal of Medicinal Chemistry releases an article titled "Identification of the Clinical Candidate PF-07284890 (ARRY-461), a Highly Potent and Brain Penetrant BRAF Inhibitor for the Treatment of Cancer". Mutations in the BRAF gene result in MAPK pathway activation that are most commonly found in human melanomas. The BRAF V600E mutation is among the most frequent types. Present BRAF inhibitors have significantly improved treatment outcomes for patients with BRAF V600-mutant cancers. However, their effectiveness is limited by disease progression in the brain as they don’t adequately penetrate the blood-brain barrier (BBB).
Pfizer’s Tinlorafenib (formerly PF 07284890) is a highly brain-penetrant inhibitor of BRAF V600-mutant tumors, and currently in a phase 1 clinical trial (NCT04543188). 

Related Products